Global and China Cancer Drug Therapy Market Insights, Forecast to 2026

Global and China Cancer Drug Therapy Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Cancer Drug Therapy Product Introduction
1.2 Market Segments
1.3 Key Cancer Drug Therapy Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Drug Therapy Market Size Growth Rate by Type
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Immunotherapy
1.5 Market by Application
1.5.1 Global Cancer Drug Therapy Market Size Growth Rate by Application
1.5.2 Angiogenesis Inhibitors
1.5.3 mTOR Inhibitors
1.5.4 Monoclonal Antibodies
1.5.5 Cytokine Immunotherapy (IL-2)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cancer Drug Therapy Market Size, Estimates and Forecasts
2.1.1 Global Cancer Drug Therapy Revenue 2015-2026
2.1.2 Global Cancer Drug Therapy Sales 2015-2026
2.2 Global Cancer Drug Therapy, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Cancer Drug Therapy Historical Market Size by Region (2015-2020)
2.3.1 Global Cancer Drug Therapy Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Cancer Drug Therapy Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Cancer Drug Therapy Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Cancer Drug Therapy Sales Forecast by Region (2021-2026)
2.4.2 Global Cancer Drug Therapy Revenue Forecast by Region (2021-2026)
3 Global Cancer Drug Therapy Competitor Landscape by Players
3.1 Global Top Cancer Drug Therapy Sales by Manufacturers
3.1.1 Global Cancer Drug Therapy Sales by Manufacturers (2015-2020)
3.1.2 Global Cancer Drug Therapy Sales Market Share by Manufacturers (2015-2020)
3.2 Global Cancer Drug Therapy Manufacturers by Revenue
3.2.1 Global Cancer Drug Therapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Cancer Drug Therapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Drug Therapy Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Drug Therapy Revenue in 2019
3.2.5 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Drug Therapy Price by Manufacturers
3.4 Global Cancer Drug Therapy Manufacturing Base Distribution, Product Types
3.4.1 Cancer Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Drug Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Drug Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Drug Therapy Market Size by Type (2015-2020)
4.1.1 Global Cancer Drug Therapy Sales by Type (2015-2020)
4.1.2 Global Cancer Drug Therapy Revenue by Type (2015-2020)
4.1.3 Cancer Drug Therapy Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Drug Therapy Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Drug Therapy Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Drug Therapy Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Drug Therapy Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Drug Therapy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cancer Drug Therapy Market Size by Application (2015-2020)
5.1.1 Global Cancer Drug Therapy Sales by Application (2015-2020)
5.1.2 Global Cancer Drug Therapy Revenue by Application (2015-2020)
5.1.3 Cancer Drug Therapy Price by Application (2015-2020)
5.2 Cancer Drug Therapy Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Drug Therapy Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Drug Therapy Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Drug Therapy Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Cancer Drug Therapy Market Size YoY Growth 2015-2026
6.1.1 China Cancer Drug Therapy Sales YoY Growth 2015-2026
6.1.2 China Cancer Drug Therapy Revenue YoY Growth 2015-2026
6.1.3 China Cancer Drug Therapy Market Share in Global Market 2015-2026
6.2 China Cancer Drug Therapy Market Size by Players (International and Local Players)
6.2.1 China Top Cancer Drug Therapy Players by Sales (2015-2020)
6.2.2 China Top Cancer Drug Therapy Players by Revenue (2015-2020)
6.3 China Cancer Drug Therapy Historic Market Review by Type (2015-2020)
6.3.1 China Cancer Drug Therapy Sales Market Share by Type (2015-2020)
6.3.2 China Cancer Drug Therapy Revenue Market Share by Type (2015-2020)
6.3.3 China Cancer Drug Therapy Price by Type (2015-2020)
6.4 China Cancer Drug Therapy Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Cancer Drug Therapy Sales Forecast by Type (2021-2026)
6.4.2 China Cancer Drug Therapy Revenue Forecast by Type (2021-2026)
6.4.3 China Cancer Drug Therapy Price Forecast by Type (2021-2026)
6.5 China Cancer Drug Therapy Historic Market Review by Application (2015-2020)
6.5.1 China Cancer Drug Therapy Sales Market Share by Application (2015-2020)
6.5.2 China Cancer Drug Therapy Revenue Market Share by Application (2015-2020)
6.5.3 China Cancer Drug Therapy Price by Application (2015-2020)
6.6 China Cancer Drug Therapy Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Cancer Drug Therapy Sales Forecast by Application (2021-2026)
6.6.2 China Cancer Drug Therapy Revenue Forecast by Application (2021-2026)
6.6.3 China Cancer Drug Therapy Price Forecast by Application (2021-2026)
7 North America
7.1 North America Cancer Drug Therapy Market Size YoY Growth 2015-2026
7.2 North America Cancer Drug Therapy Market Facts & Figures by Country
7.2.1 North America Cancer Drug Therapy Sales by Country (2015-2020)
7.2.2 North America Cancer Drug Therapy Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Cancer Drug Therapy Market Size YoY Growth 2015-2026
8.2 Europe Cancer Drug Therapy Market Facts & Figures by Country
8.2.1 Europe Cancer Drug Therapy Sales by Country
8.2.2 Europe Cancer Drug Therapy Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Cancer Drug Therapy Market Size YoY Growth 2015-2026
9.2 Asia Pacific Cancer Drug Therapy Market Facts & Figures by Country
9.2.1 Asia Pacific Cancer Drug Therapy Sales by Region (2015-2020)
9.2.2 Asia Pacific Cancer Drug Therapy Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Cancer Drug Therapy Market Size YoY Growth 2015-2026
10.2 Latin America Cancer Drug Therapy Market Facts & Figures by Country
10.2.1 Latin America Cancer Drug Therapy Sales by Country
10.2.2 Latin America Cancer Drug Therapy Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Drug Therapy Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Drug Therapy Sales by Country
11.2.2 Middle East and Africa Cancer Drug Therapy Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Amgen / Allergan
12.1.1 Amgen / Allergan Corporation Information
12.1.2 Amgen / Allergan Description and Business Overview
12.1.3 Amgen / Allergan Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
12.1.5 Amgen / Allergan Recent Development
12.2 Argos Therapeutics
12.2.1 Argos Therapeutics Corporation Information
12.2.2 Argos Therapeutics Description and Business Overview
12.2.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
12.2.5 Argos Therapeutics Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Description and Business Overview
12.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AstraZeneca Cancer Drug Therapy Products Offered
12.3.5 AstraZeneca Recent Development
12.4 Aveo Pharmaceuticals
12.4.1 Aveo Pharmaceuticals Corporation Information
12.4.2 Aveo Pharmaceuticals Description and Business Overview
12.4.3 Aveo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
12.4.5 Aveo Pharmaceuticals Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Description and Business Overview
12.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer Cancer Drug Therapy Products Offered
12.5.5 Bayer Recent Development
12.6 Exelixis
12.6.1 Exelixis Corporation Information
12.6.2 Exelixis Description and Business Overview
12.6.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Exelixis Cancer Drug Therapy Products Offered
12.6.5 Exelixis Recent Development
12.7 Incyte
12.7.1 Incyte Corporation Information
12.7.2 Incyte Description and Business Overview
12.7.3 Incyte Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Incyte Cancer Drug Therapy Products Offered
12.7.5 Incyte Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Description and Business Overview
12.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Cancer Drug Therapy Products Offered
12.8.5 Merck Recent Development
12.9 Roche
12.9.1 Roche Corporation Information
12.9.2 Roche Description and Business Overview
12.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Roche Cancer Drug Therapy Products Offered
12.9.5 Roche Recent Development
12.10 Bristol-Myers Squibb
12.10.1 Bristol-Myers Squibb Corporation Information
12.10.2 Bristol-Myers Squibb Description and Business Overview
12.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
12.10.5 Bristol-Myers Squibb Recent Development
12.11 Amgen / Allergan
12.11.1 Amgen / Allergan Corporation Information
12.11.2 Amgen / Allergan Description and Business Overview
12.11.3 Amgen / Allergan Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Amgen / Allergan Cancer Drug Therapy Products Offered
12.11.5 Amgen / Allergan Recent Development
12.12 Exelixis
12.12.1 Exelixis Corporation Information
12.12.2 Exelixis Description and Business Overview
12.12.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Exelixis Products Offered
12.12.5 Exelixis Recent Development
12.13 Genentech (Roche)
12.13.1 Genentech (Roche) Corporation Information
12.13.2 Genentech (Roche) Description and Business Overview
12.13.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Genentech (Roche) Products Offered
12.13.5 Genentech (Roche) Recent Development
12.14 Novartis
12.14.1 Novartis Corporation Information
12.14.2 Novartis Description and Business Overview
12.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Novartis Products Offered
12.14.5 Novartis Recent Development
12.15 Pfizer
12.15.1 Pfizer Corporation Information
12.15.2 Pfizer Description and Business Overview
12.15.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Pfizer Products Offered
12.15.5 Pfizer Recent Development
12.16 Prometheus Labs
12.16.1 Prometheus Labs Corporation Information
12.16.2 Prometheus Labs Description and Business Overview
12.16.3 Prometheus Labs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Prometheus Labs Products Offered
12.16.5 Prometheus Labs Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Cancer Drug Therapy Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Drug Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Cancer Drug Therapy Market Segments
Table 2. Ranking of Global Top Cancer Drug Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cancer Drug Therapy Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Targeted Therapy
Table 5. Major Manufacturers of Chemotherapy
Table 6. Major Manufacturers of Immunotherapy
Table 7. Global Cancer Drug Therapy Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Cancer Drug Therapy Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Cancer Drug Therapy Sales by Regions 2015-2020 (K Units)
Table 10. Global Cancer Drug Therapy Sales Market Share by Regions (2015-2020)
Table 11. Global Cancer Drug Therapy Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Cancer Drug Therapy Sales Forecast by Region (2021-2026) (K Units)
Table 13. Global Cancer Drug Therapy Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Cancer Drug Therapy Sales Share by Manufacturers (2015-2020)
Table 15. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Drug Therapy as of 2019)
Table 17. Cancer Drug Therapy Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Cancer Drug Therapy Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Cancer Drug Therapy Price (2015-2020) (USD/Unit)
Table 20. Cancer Drug Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Cancer Drug Therapy Product Type
Table 22. Date of International Manufacturers Enter into Cancer Drug Therapy Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Drug Therapy Sales by Type (2015-2020) (K Units)
Table 25. Global Cancer Drug Therapy Sales Share by Type (2015-2020)
Table 26. Global Cancer Drug Therapy Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Cancer Drug Therapy Revenue Share by Type (2015-2020)
Table 28. Cancer Drug Therapy Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Cancer Drug Therapy Sales Share by Type (2021-2026)
Table 30. Global Cancer Drug Therapy Sales by Application (2015-2020) (K Units)
Table 31. Global Cancer Drug Therapy Sales Share by Application (2015-2020)
Table 32. Global Cancer Drug Therapy Sales Share by Application (2021-2026)
Table 33. Global Cancer Drug Therapy Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Cancer Drug Therapy Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Cancer Drug Therapy Revenue Market Share Forecast by Application (2021-2026)
Table 36. China Cancer Drug Therapy Sales (K Units) of Key Companies (2015-2020)
Table 37. China Cancer Drug Therapy Sales Share by Company (2015-2020)
Table 38. China Cancer Drug Therapy Revenue (US$ Million) by Company (2015-2020)
Table 39. China Cancer Drug Therapy Sales (K Units) by Type (2015-2020)
Table 40. China Cancer Drug Therapy Sales Share by Type (2015-2020)
Table 41. China Cancer Drug Therapy Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. China Cancer Drug Therapy Price (K Units) by Type (2015-2020)
Table 43. China Cancer Drug Therapy Sales (K Units) by Type (2021-2026)
Table 44. China Cancer Drug Therapy Sales Share by Type (2021-2026)
Table 45. China Cancer Drug Therapy Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. China Cancer Drug Therapy Revenue Share by Type (2021-2026)
Table 47. China Cancer Drug Therapy Price (K Units) by Type (2021-2026)
Table 48. China Cancer Drug Therapy Sales (K Units) by Application (2015-2020)
Table 49. China Cancer Drug Therapy Sales Share by Application (2015-2020)
Table 50. China Cancer Drug Therapy Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. China Cancer Drug Therapy Sales (K Units) by Application (2021-2026)
Table 52. China Cancer Drug Therapy Sales Share by Application (2021-2026)
Table 53. China Cancer Drug Therapy Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. China Cancer Drug Therapy Revenue Share by Application (2021-2026)
Table 55. North America Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 56. North America Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 57. North America Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 59. Europe Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 60. Europe Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 61. Europe Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Cancer Drug Therapy Sales by Region (2015-2020) (K Units)
Table 64. Asia Pacific Cancer Drug Therapy Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Cancer Drug Therapy Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region (2015-2020)
Table 67. Latin America Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 68. Latin America Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 72. Middle East and Africa Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 75. Amgen / Allergan Corporation Information
Table 76. Amgen / Allergan Description and Business Overview
Table 77. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Amgen / Allergan Cancer Drug Therapy Product
Table 79. Amgen / Allergan Recent Development
Table 80. Argos Therapeutics Corporation Information
Table 81. Argos Therapeutics Description and Business Overview
Table 82. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Argos Therapeutics Product
Table 84. Argos Therapeutics Recent Development
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. AstraZeneca Product
Table 89. AstraZeneca Recent Development
Table 90. Aveo Pharmaceuticals Corporation Information
Table 91. Aveo Pharmaceuticals Description and Business Overview
Table 92. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Aveo Pharmaceuticals Product
Table 94. Aveo Pharmaceuticals Recent Development
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bayer Product
Table 99. Bayer Recent Development
Table 100. Exelixis Corporation Information
Table 101. Exelixis Description and Business Overview
Table 102. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Exelixis Product
Table 104. Exelixis Recent Development
Table 105. Incyte Corporation Information
Table 106. Incyte Description and Business Overview
Table 107. Incyte Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Incyte Product
Table 109. Incyte Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Merck Product
Table 114. Merck Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Roche Product
Table 119. Roche Recent Development
Table 120. Bristol-Myers Squibb Corporation Information
Table 121. Bristol-Myers Squibb Description and Business Overview
Table 122. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Bristol-Myers Squibb Product
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Eisai Corporation Information
Table 126. Eisai Description and Business Overview
Table 127. Eisai Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Eisai Product
Table 129. Eisai Recent Development
Table 130. Exelixis Corporation Information
Table 131. Exelixis Description and Business Overview
Table 132. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Exelixis Product
Table 134. Exelixis Recent Development
Table 135. Genentech (Roche) Corporation Information
Table 136. Genentech (Roche) Description and Business Overview
Table 137. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Genentech (Roche) Product
Table 139. Genentech (Roche) Recent Development
Table 140. Novartis Corporation Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Novartis Product
Table 144. Novartis Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Description and Business Overview
Table 147. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Pfizer Product
Table 149. Pfizer Recent Development
Table 150. Prometheus Labs Corporation Information
Table 151. Prometheus Labs Description and Business Overview
Table 152. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Prometheus Labs Product
Table 154. Prometheus Labs Recent Development
Table 155. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 156. Key Challenges
Table 157. Market Risks
Table 158. Main Points Interviewed from Key Cancer Drug Therapy Players
Table 159. Cancer Drug Therapy Customers List
Table 160. Cancer Drug Therapy Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Drug Therapy Product Picture
Figure 2. Global Cancer Drug Therapy Sales Market Share by Type in 2020 & 2026
Figure 3. Targeted Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Global Cancer Drug Therapy Sales Market Share by Application in 2020 & 2026
Figure 7. Angiogenesis Inhibitors
Figure 8. mTOR Inhibitors
Figure 9. Monoclonal Antibodies
Figure 10. Cytokine Immunotherapy (IL-2)
Figure 11. Cancer Drug Therapy Report Years Considered
Figure 12. Global Cancer Drug Therapy Market Size 2015-2026 (US$ Million)
Figure 13. Global Cancer Drug Therapy Sales 2015-2026 (K Units)
Figure 14. Global Cancer Drug Therapy Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Cancer Drug Therapy Sales Market Share by Region (2015-2020)
Figure 16. Global Cancer Drug Therapy Sales Market Share by Region in 2019
Figure 17. Global Cancer Drug Therapy Revenue Market Share by Region (2015-2020)
Figure 18. Global Cancer Drug Therapy Revenue Market Share by Region in 2019
Figure 19. Global Cancer Drug Therapy Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Cancer Drug Therapy Revenue in 2019
Figure 21. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Cancer Drug Therapy Sales Market Share by Type (2015-2020)
Figure 23. Global Cancer Drug Therapy Sales Market Share by Type in 2019
Figure 24. Global Cancer Drug Therapy Revenue Market Share by Type (2015-2020)
Figure 25. Global Cancer Drug Therapy Revenue Market Share by Type in 2019
Figure 26. Global Cancer Drug Therapy Market Share by Price Range (2015-2020)
Figure 27. Global Cancer Drug Therapy Sales Market Share by Application (2015-2020)
Figure 28. Global Cancer Drug Therapy Sales Market Share by Application in 2019
Figure 29. Global Cancer Drug Therapy Revenue Market Share by Application (2015-2020)
Figure 30. Global Cancer Drug Therapy Revenue Market Share by Application in 2019
Figure 31. China Cancer Drug Therapy Sales Growth Rate 2015-2026 (K Units)
Figure 32. China Cancer Drug Therapy Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. China Cancer Drug Therapy Market Share in Global Market 2015-2026
Figure 34. China 5 and 10 Largest Cancer Drug Therapy Players Market Share by Revenue in Cancer Drug Therapy in 2019
Figure 35. China Cancer Drug Therapy Revenue Share by Type (2015-2020)
Figure 36. China Cancer Drug Therapy Revenue Growth Rate by Type in 2015 & 2019
Figure 37. China Cancer Drug Therapy Revenue Share by Application (2015-2020)
Figure 38. China Cancer Drug Therapy Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America Cancer Drug Therapy Sales Growth Rate 2015-2020 (K Units)
Figure 40. North America Cancer Drug Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 42. North America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 43. U.S. Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 44. U.S. Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 46. Canada Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe Cancer Drug Therapy Sales Growth Rate 2015-2020 (K Units)
Figure 48. Europe Cancer Drug Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 50. Europe Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 51. Germany Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 52. Germany Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 54. France Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 56. U.K. Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 58. Italy Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 60. Russia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific Cancer Drug Therapy Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific Cancer Drug Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Cancer Drug Therapy Sales Market Share by Region in 2019
Figure 64. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region in 2019
Figure 65. China Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 66. China Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 72. India Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America Cancer Drug Therapy Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Cancer Drug Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 90. Latin America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 91. Mexico Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa Cancer Drug Therapy Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Cancer Drug Therapy Revenue Growth Rate 2015-2020 (US$ Million)
Figu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs